Trade Mark Journal No.2026/039 25 September 2026
UK00004445090 14 September 2026 (5)
AGALZYME
- Class 5
- A medicinal product for human use indicated for the treatment of fabry disease.
BIOSIDUS S.A.U.
Representative: Simmons & Simmons LLP
AGALZYME
BIOSIDUS S.A.U.
Representative: Simmons & Simmons LLP